Sanofi has appointed Belén Garijo, the CEO of Merck KGaA, as its new chief executive following the decision not to renew Paul Hudson's mandate, amid investor concerns and declining vaccine demand.
Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson(current)